American Physician Institute

Guaranteed Board Review Courses

Update on Anti-Obesity Medications

Lightning Reviews - Fast CME courses Update on Anti-Obesity Medications - Fast CME Course

Detailed, Practical Advice You Need to Create Patient-Specific Obesity Treatment Plans

All New Content Released March 2025.
Only $97 through March 15!

Register Now!

//////////// SLIDER //////////// SLIDER //////////// SLIDER ////////////

Focused Learning Course on Anti-Obesity Medications. You’ll learn to…

Limited Time Offer – Only $97! Discount ends March 15.

Update on Anti-Obesity Medications

$149 $149
 Register Now

100% Money Back Guarantee – See Terms & Conditions

Update on Anti-Obesity Medications for Creating Effective Treatment Plans

With the growing number of options on the market – more medications in more classes – this course helps you make the best possible treatment decisions. Patients these days enter your office both with more questions than ever and with more informed opinions after having done their own ‘research.’ Now you’ll be prepared with up-to-date details on the full range of medication options available in 2025. Increase your knowledge, make better decisions, and speed discussions with patients and writing of progress notes.

Topics Covered
  • Practical Medication Access Solutions
  • Optimizing Anti-Obesity Medication Use
  • Managing Medication Challenges
  • Personalized Obesity Treatment Strategies
Course Benefits
  • All lectures available now
  • 4 AMA PRA Category 1 CME Credits™ included
  • Course syllabus pdf with all slide content
  • 12-month access to course recordings

Update on Anti-Obesity Medications Course Agenda

Practical Solutions for Medication Access I & II – Laura Davisson, MD

  • Recognize that obesity is treatable
  • Describe the four pillars of obesity medicine and the spectrum of treatment options along the obesity severity continuum
  • Recognize the components of the medical pillar in obesity medicine
  • Consistently diagnose obesity and implement a management plan to address it
  • Identify common medications that are associated with weight gain or weight loss
  • Use knowledge of the weight properties of common medications to optimize medications for weight management

Unlocking the Potential of AOMs I & II – Laura Davisson, MD

  • Prescribe the diabetes mellitus type 2 class of medications in an optimal manner for weight management, including for uses beyond diabetes
  • Recognize the importance of careful patient selection criteria for anti-obesity medications
  • Confidently prescribe bupropion/naltrexone (Contrave®)
  • Confidently prescribe phentermine/topiramate (Qsymia®)
  • Describe the approved and off-label uses of anti-obesity medications, including regulations for duration of use

When Medications Miss the Mark – Laura Davisson, MD

  • Confidently prescribe glucagon-like peptide-1 (GLP-1) receptor agonists
  • Confidently prescribe dual GLP-1/GIP agonists
  • Effectively manage common problems seen with the GLP-1 agonist-related medication class
  • Recognize upcoming anti-obesity medications in the pipeline
  • Confidently prescribe and troubleshoot orlistat

Wrapping Up Obesity Treatment – Laura Davisson, MD

  • Recognize rare genetic disorders of obesity that may be FDA-approved indications for setmelanotide
  • Understand the indications and procedure for prescribing gelesis100
  • Counsel patients about medications that are not recommended for weight loss
  • Individualize obesity treatment for patients with liver, kidney, or cardiac conditions
  • Treat obesity in special populations, including individuals who could get pregnant, bariatric surgery patients, geriatric patients, and others
  • Understand barriers to treatment and how to help patients advocate for access to obesity treatments
Faculty
faculty member Laura Davisson, MD
Laura Davisson, MD

Laura Davisson, MD, MPH, FACP, is a Professor in the Department of Internal Medicine. She received her undergraduate degree from Northwestern University. She earned her medical degree and MPH from West Virginia University (WVU). Dr. Davisson completed an Internal Medicine residency at WVU and served as Chief Resident. She is board certified by the American Board of Internal Medicine and the American Board of Obesity Medicine.
After years of practicing Internal Medicine with an outpatient focus on women’s health and prevention, Dr. Davisson recognized the contribution of obesity to many chronic conditions she treated. This motivated her to get additional training to specialize in obesity treatment. She founded and now directs WVU Medicine’s Medical Weight Management program, which works in collaboration with Bariatric Surgery in the WVU Medicine Medical and Surgical Weight Loss Center.

Dr. Davisson is active in medical education. As Associate Program Director, she directs internal medicine resident quality improvement activities and the residency research track. She is the WVU School of Medicine Nutrition Curriculum Thread Director. To reach Dr. Davisson’s goal of creating a regional workforce to treat obesity, the Medical Weight Management clinic serves as a training site for students, residents, and fellows. Dr. Davisson is the Founder and Program Director for WVU’s Nutrition and Metabolic Diseases Fellowship which is the first program in WV to train fellows in obesity medicine skills.

Dr. Davisson has been active in the American College of Physicians (ACP) and was granted ACP fellowship in 2009. She was elected as ACP’s WV Chapter Governor, serving a four-year term on the ACP Board of Governors until April 2023. Dr. Davisson serves on committees for the Obesity Medicine Association (OMA) and American Board of Obesity Medicine. She has been a contributing author for OMA’s Obesity Algorithm. Dr. Davisson enjoys participating in outreach activities, such as speaking and writing on various health topics and advocating for the prevention and treatment of obesity and related illnesses.

CME Accreditation

Accreditation Statement:
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of PeerPoint Medical Education Institute and American Physician Institute for Advanced Professional Studies, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to sponsor continuing medical education for physicians.

Designation Statement:
Online Course, Release Date March 1, 2025, Termination Date February 29, 2028:
PeerPoint Medical Education Institute designates the live and enduring formats for this educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

MOC Accreditation Statement:
Successful completion of this CME activity enables the participant to earn up to 4 MOC points in the American Board of Internal Medicine’s (ABIM®) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM® MOC points.

Nurses & Nurse Practitioners: For all your CE requirements for recertification, the ANCC will accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Physician Assistants: The NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Licensed Psychologists: Most state boards will accept AMA PRA Category 1 Credits™ toward professional development hours. Please confirm with your state board before using this product for professional development hours.

Learn to Support and Empower Your Patients with Appropriate Weight Loss Treatment

Weight management medications encompass a range of mechanisms to combat the challenges of excess weight. Some are designed to reduce hunger pangs and promote early satiety, enabling better portion control. Others help the body burn more calories by increasing metabolism. Still, others inhibit the body’s absorption of dietary fats, ultimately decreasing a person’s overall calorie consumption.

Which medications are right for each of your patients? This course will help you know.

The best obesity treatment for a particular patient will depend on their individual needs and circumstances. Some factors to consider include the patient’s age, weight, health history, and other medications they are taking.

Common weight loss medications covered in this course:

By staying informed about the latest advancements in weight management medications, you can help your patients achieve their weight loss goals and improve their overall health. Some of the most common anti-obesity medications for weight loss treatment covered in this course include:

  • Semaglutide (Wegovy): This medication is a newer once weekly injectable medication that works by mimicking a gut hormone that helps regulate appetite.
  • Liraglutide (Saxenda): This medication is a daily injectable medication that works by mimicking a gut hormone that helps regulate appetite.
  • Orlistat (Xenical, Alli): This medication works by blocking fat absorption from food.
  • Phentermine (Adipex-P): This medication is a stimulant that suppresses appetite.
  • Topiramate/phentermine (Qsymina): This medication combines two medications to suppress appetite.
  • Naltrexone/bupropion (Contrave): This medication combines two medications that work together to reduce hunger and increase energy expenditure.
  • Up-and-coming medications in the pipeline and off label use of medications to promote weight loss

Embrace the opportunity to significantly impact your patients’ health and well-being by learning about the treatment of obesity with anti-obesity medications.

Better Advocate for Your Patients with Our Updates on Anti-Obesity Medications Course

With our Updates on Anti-Obesity Medications course, you can unlock the potential of effective weight loss treatment with medications and guide your patients to live their best, healthiest lives. Enhance your ability to provide appropriate care and improve patient outcomes by garnering knowledge about the diverse medications for the treatment of overweight patients and those with obesity.

Limited Time Offer – Only $97! Discount ends March 15.

Update on Anti-Obesity Medications

$149 $149
Register Now

Government Sales – SAM.gov
Unique Entity ID: LQWHFPP2KLB8

Customer Care: 877-225-8384
M-F, 8:30am – 5:00pm (CST)

American Physician Institute for Advanced Professional Studies, LLC BBB Business Review